Ellevest Inc’s Biodesix BDSX Stock Holding History

Ellevest Inc’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7	Closed	–	–	1850
2022 Q3	$0	Hold	7	–	–	﹤0.01%	1609
2022 Q2	$0	Buy	+7	New	+$228	﹤0.01%	1402
2022 Q1	–	Sell	-2	Closed	–	–	1420
2021 Q4	$0	Buy	2 +1	+100%	+$131	﹤0.01%	1420
2021 Q3	$0	Buy	+1	New	+$190	﹤0.01%	1407

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Ellevest Inc's BDSX Position: Q4 2022 in Review

Ellevest Inc sold out of Biodesix (BDSX) in Q4 2022, closing a stake of 7 shares.

Ellevest Inc first reported a position in BDSX in Q3 2021 and held it in 4 quarters. The position peaked at $0 in Q3 2022. 33 funds tracked by Wall St. Rank hold BDSX as of Q4 2022.

Ellevest Inc reported no remaining Biodesix position as of Q4 2022 after selling out during the quarter.
Ellevest Inc sold 7 Biodesix shares in Q4 2022.
Ellevest Inc first reported a position in Biodesix in Q3 2021 and held it in 4 quarters.
Ellevest Inc's Biodesix position peaked at $0 in Q3 2022.
33 funds tracked by Wall St. Rank held Biodesix as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.